In the face of a major shift in practice due to COVID-19, it is vital for specialist allergy and immunology services to develop a robust local strategy that will allow provision of services to patients with allergic and immunological conditions in a safe and effective manner, making efficient use of the limited resources we have, while protecting the health of patients and staff. As a result we have been working on this ‘Service Recovery Document’ document which outlines some general principles which may be helpful in developing ways to achieve this locally, taking into account the complex nature of specialist service provision.
BSACI in conjunction with the Resuscitation Council UK, the RCGP and Public Health England, have produced updated information for use in any vaccination setting to give clear guidance to healthcare professionals involved. Click here to view this. There is also poster of the algorithm for the management of anaphylaxis in the vaccination setting.
Herewith a collated list of adult drug allergy clinics from the BSACI allergy service finder.
Allergy In the Post COVID-19 World Webinar 2, Monday 29th June 2020
Allergy In the Post COVID-19 World webinar 1 Monday 1st June 2020
MODIFICATIONS FOR ADULT ALLERGY SERVICES DURING COVID-19 PANDEMIC
MODIFICATIONS FOR PAEDIATRIC ALLERGY SERVICES DURING COVID-19 PANDEMIC
Allergy in ICD-11 NL12 Newsletter
RCPsych – Top ten messages for supporting healthcare staff during the COVID – 19 Pandemic
BAD Guidance for Managing Urticaria Patients on Omalizumab during the Coronavirus Pandemic.
BAD – Dermatology Advice Regarding Immunosuppressed Patients: Adults, Paediatrics and Young People